[ Disclaimer: The information on GoldBamboo for any particular treatment, medicine, drug, or herbal product might be missing or incomplete, and should never be used as a single source of knowledge. GoldBamboo generally has links to authoritative sites displayed toward the bottom of each topic page under the heading "Resources". ]
Well Water Quality |
|
|
Clinical Trial: Quality of Life Assessment of Patients Receiving Treatment for Esophageal Cancer
This study is no longer recruiting patients.
Purpose
RATIONALE: Questionnaires that measure quality of life during treatment may improve the ability to plan treatment for patients with esophageal cancer.
PURPOSE: Study to evaluate quality of life of patients receiving treatment for esophageal cancer.
| Condition |
|---|
| psychosocial effects/treatment Quality of Life |
MedlinePlus consumer health information
Study Type: Observational
Study Design: Longitudinal
Official Title: Companion Study to Evaluate Quality of Life and Cost of Treatment in Patients With Esophageal Cancer Enrolled on CALGB C9781
Study start: July 1998
OBJECTIVES: I. Evaluate the quality of life of patients with esophageal cancer randomized on protocol CALGB C9781 to treatment with surgery alone vs trimodal therapy combining preoperative chemotherapy and radiation therapy in addition to surgery.
II. Examine the incremental cost and cost effectiveness of preoperative chemotherapy and radiation therapy in the treatment of esophageal cancer.
III. Examine the incremental cost per quality-adjusted life year (QALY) of preoperative chemotherapy and radiation therapy in the treatment of esophageal cancer.
PROTOCOL OUTLINE: This is a companion study to CALGB C9781, a phase III randomized study.
Prior to treatment on CALGB C9781, patients complete forms assessing quality of life, psychological functioning, specific areas of dysfunction, resource use, and time lost from work; subsequent assessments are completed by telephone interview at 1, 2, 6, 12, 18, and 24 months after the initiation of study treatment, regardless of disease status (patients with hearing impairment and those speaking only a translatable foreign language may mail responses). Patients also keep a diary of medical resource utilization at sites other than the treating institution.
PROJECTED ACCRUAL: Approximately 180 patients will be accrued to this study.
Eligibility
Ages Eligible for Study: 18 Years and above
Criteria
PROTOCOL ENTRY CRITERIA:
--Disease Characteristics--
- Patients with esophageal cancer enrolled on protocol CALGB-C9781
--Patient Characteristics--
- Age: 18 and over
- Patient able to communicate in English or Spanish
Location Information
Alabama
Veterans Affairs Medical Center - Birmingham, Birmingham, Alabama, 35233, United States
California
UCSF Cancer Center and Cancer Research Institute, San Francisco, California, 94115-0128, United States
University of California San Diego Cancer Center, La Jolla, California, 92093-0658, United States
Veterans Affairs Medical Center - San Francisco, San Francisco, California, 94121, United States
Delaware
CCOP - Christiana Care Health Services, Wilmington, Delaware, 19899, United States
District of Columbia
Walter Reed Army Medical Center, Washington, District of Columbia, 20307-5000, United States
Florida
CCOP - Mount Sinai Medical Center, Miami Beach, Florida, 33140, United States
Illinois
University of Chicago Cancer Research Center, Chicago, Illinois, 60637, United States
University of Illinois at Chicago Health Sciences Center, Chicago, Illinois, 60612, United States
Veterans Affairs Medical Center - Chicago (Westside Hospital), Chicago, Illinois, 60612, United States
Iowa
University of Iowa Hospitals and Clinics, Iowa City, Iowa, 52242, United States
Maine
Veterans Affairs Medical Center - Togus, Togus, Maine, 04330, United States
Maryland
Marlene & Stewart Greenebaum Cancer Center, University of Maryland, Baltimore, Maryland, 21201, United States
Massachusetts
Dana-Farber Cancer Institute, Boston, Massachusetts, 02115, United States
University of Massachusetts Memorial Medical Center, Worcester, Massachusetts, 01655, United States
Minnesota
Veterans Affairs Medical Center - Minneapolis, Minneapolis, Minnesota, 55417, United States
Missouri
Barnes-Jewish Hospital, Saint Louis, Missouri, 63110, United States
Ellis Fischel Cancer Center - Columbia, Columbia, Missouri, 65203, United States
Veterans Affairs Medical Center - Columbia (Truman Memorial), Columbia, Missouri, 65201, United States
Nebraska
University of Nebraska Medical Center, Omaha, Nebraska, 68198-3330, United States
Nevada
CCOP - Southern Nevada Cancer Research Foundation, Las Vegas, Nevada, 89106, United States
New Hampshire
Norris Cotton Cancer Center, Lebanon, New Hampshire, 03756, United States
New York
CCOP - North Shore University Hospital, Manhasset, New York, 11030, United States
CCOP - Syracuse Hematology-Oncology Associates of Central New York, P.C., Syracuse, New York, 13210, United States
Memorial Sloan-Kettering Cancer Center, New York, New York, 10021, United States
Mount Sinai Medical Center, NY, New York, New York, 10029, United States
New York Presbyterian Hospital - Cornell Campus, New York, New York, 10021, United States
North Shore University Hospital, Manhasset, New York, 11030, United States
State University of New York - Upstate Medical University, Syracuse, New York, 13210, United States
Veterans Affairs Medical Center - Buffalo, Buffalo, New York, 14215, United States
Veterans Affairs Medical Center - Syracuse, Syracuse, New York, 13210, United States
North Carolina
CCOP - Southeast Cancer Control Consortium, Winston Salem, North Carolina, 27104-4241, United States
Comprehensive Cancer Center of Wake Forest University Baptist Medical Center, Winston Salem, North Carolina, 27157-1082, United States
Duke Comprehensive Cancer Center, Durham, North Carolina, 27710, United States
Lineberger Comprehensive Cancer Center, UNC, Chapel Hill, North Carolina, 27599-7295, United States
Veterans Affairs Medical Center - Durham, Durham, North Carolina, 27705, United States
Rhode Island
Rhode Island Hospital, Providence, Rhode Island, 02903, United States
South Carolina
Medical University of South Carolina, Charleston, South Carolina, 29425-0721, United States
Tennessee
University of Tennessee, Memphis Cancer Center, Memphis, Tennessee, 38163, United States
Veterans Affairs Medical Center - Memphis, Memphis, Tennessee, 38104, United States
Vermont
Vermont Cancer Center, Burlington, Vermont, 05401-3498, United States
Veterans Affairs Medical Center - White River Junction, White River Junction, Vermont, 05009, United States
Virginia
MBCCOP - Massey Cancer Center, Richmond, Virginia, 23298-0037, United States
Veterans Affairs Medical Center - Richmond, Richmond, Virginia, 23249, United States
More Information
Clinical trial summary from the National Cancer Institute's PDQ® database
Record last reviewed: June 2004
Last Updated: October 13, 2004
Record first received: November 1, 1999
ClinicalTrials.gov Identifier: NCT00003381
Health Authority: United States: Federal Government
ClinicalTrials.gov processed this record on 2005-04-08
Source: ClinicalTrials.gov
Cache Date: April 9, 2005

Not Signed In -


